Key Statistics for 874
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (CNY) (ttm)
|Est. EPS (CNY) (12/2013)
|Est. PEG Ratio
|Market Cap (M HKD)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (CNY)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 874
- Net Income (M/CNY)
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. manufactures and sells Chinese patent medicine. The Company also wholesales, retails, imports, and exports Western and Chinese pharmaceutical products and various medical apparatus.
More Company Profile & Key Executives for 874
|Li ChuyuanChairman||Wu ChanghaiGeneral Mgr/Exec Dir|
|Su GuangfengDeputy General Manager||Chen BinghuaController/Senior Mgr:Finance|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.